Renin–Angiotensin–Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study

Mostrar otras versiones (1)

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may increase the risk of coronavirus disease 2019 (COVID-19) infection or affect disease severity. Prior studies have not examined risks by medication dose. METHODS: This retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Dublin, Sascha, Walker, Rod L, Floyd, James S, Shortreed, Susan M, Fuller, Sharon, Albertson-Junkans, Ladia, Harrington, Laura B, Greenwood-Hickman, Mikael Anne, Green, Beverly B, Psaty, Bruce M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665332/
https://www.ncbi.nlm.nih.gov/pubmed/33048112
http://dx.doi.org/10.1093/ajh/hpaa168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665332/
https://www.ncbi.nlm.nih.gov/pubmed/33048112
http://dx.doi.org/10.1093/ajh/hpaa168

Ejemplares similares